Skip to main content
Premium Trial:

Request an Annual Quote

Issues From the Start

A German university found evidence that a researcher who developed a controversial blood test for breast cancer committed scientific misconduct, according to Science. It adds that the researcher, Heidelberg University Hospital's Christof Sohn, petitioned a court to block the release of the university's report.

As GenomeWeb reported in March the German molecular diagnostics company HeiScreen announced it was developing a liquid biopsy-based test to detect breast cancer based on work out of Heidelberg. The company claimed the test had a sensitivity of between 80 percent and 90 percent and would be of particular use to women under the age of 50 with high familial risk of breast cancer. But as GenomeWeb reported, some researchers were skeptical about the company's claims and wanted more data, especially about its specificity.

According to Science, some of these claims were contradicted by data Sohn presented at a scientific conference, which included that the test had a specificity of 45 percent to 73 percent.

Heidelberg conducted both an internal and external investigation into the matter and found evidence of "extensive and severe scientific misconduct" by Sohn, Science reports. It adds the new report from a university commission indicated before it was taken down that that there were scientific issues "from the beginning of the research on the blood test, and since then continuously."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.